Moreover, according to the analyses published on GEO database (https://www.ncbi.nlm.nih.gov/geoprofiles), we found two datasets that exhibited KIF2A expressions in AML patients and normal controls (Figure S1): in detail, one dataset showed that KIF2A expression was increased in the bone marrow samples of pediatric AML patients compared to that of normal controls (Figure S1A), and the other one showed that KIF2A expression was similar between the bone samples of AML patients and those of normal controls (Figure S1B). The gene discussed is KIF2A; the disease is acute myeloid leukemia.